Annexes to COM(2017)72 - EU position in the sixtieth session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961 - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
dossier | COM(2017)72 - EU position in the sixtieth session of the Commission on Narcotic Drugs on the scheduling of substances under the Single ... |
---|---|
document | COM(2017)72 ![]() |
date | March 7, 2017 |
Position to be taken by the Member States which are members of the Commission on Narcotic Drugs acting jointly in the interest of the Union during the 60th session of the Commission on Narcotic Drugs on 13 to 17 March 2017 regarding changes in the scope of control of substances:
(1) | U-47700 is to be included in Schedule I of the Single Convention of Narcotic Drugs of 1961 as amended by the 1972 Protocol. |
(2) | Butyrfentanyl is to be included in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol. |
(3) | 4-MEC (4-methylethcathinone) is to be included in Schedule II of 1971 Convention on Psychotropic Substances. |
(4) | Ethylone is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(5) | Pentedrone (α-methylaminovalerophenone) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(6) | Ethylphenidate (EPH) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(7) | MPA (methiopropamine) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(8) | MDMB-CHMICA is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(9) | 5F-APINACA (5F-AKB48) is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |
(10) | XLR-11 is to be included in Schedule II of the Convention on Psychotropic Substances of 1971. |